TY  - GEN
AU  - Jia,Xiaoming
AU  - Akeroyd,Julia M
AU  - Nasir,Khurram
AU  - Nambi,Vijay
AU  - Ballantyne,Christie M
AU  - Petersen,Laura A
AU  - Virani,Salim S
TI  - Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial
SN  - 1524-4539
PY  - 2019///1219
KW  - Atherosclerosis
KW  - blood
KW  - Biomarkers
KW  - Clinical Decision-Making
KW  - Clinical Trials as Topic
KW  - Drug Costs
KW  - Dyslipidemias
KW  - Eicosapentaenoic Acid
KW  - adverse effects
KW  - Eligibility Determination
KW  - economics
KW  - Humans
KW  - Hypolipidemic Agents
KW  - Lipids
KW  - Multicenter Studies as Topic
KW  - Patient Selection
KW  - Risk Factors
KW  - Treatment Outcome
KW  - United States
KW  - epidemiology
KW  - United States Department of Veterans Affairs
KW  - Veterans Health Services
N1  - Publication Type: Letter; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1161/CIRCULATIONAHA.118.038691
ER  -